NCT06040099 · Interventional trial
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE
Overall registry status Active not recruiting
Phase 2
Conditions Hepatocellular Carcinoma (HCC)
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
- Research Site · Trenton, NJ · Mercer County
First posted
Registry updated
Added to the directory